ACLX Competitors & Alternatives
Compare Arcellx Inc with similar stocks in the same industry
Biotechnology
ACLX
Main Stock$115.07
Tradestie Score
50
Market Cap
$4.55B
Revenue Growth
-0.9%
Analyst Upside
-1.9%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$77.67
|
$6.68B | - | 67 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$112.22
|
$6.64B | - | 57 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$117.91
|
$6.38B | - | 50 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$21.37
|
$6.03B | - | 48 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$61.04
|
$6.02B | - | 39 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$200.77
|
$5.92B | - | 54 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.19
|
$5.80B | 19.8 | 45 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$356.43
|
$5.20B | 43.5 | 50 | Compare |
More ACLX Analysis
Data updated: Aug 25, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry